Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-25-203540

Director bought 20,400 shares at $24.48 ($499,374)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huber Reid M Director 2025-09-12 Purchase +20,400 $24.48 $499,374 20,400 D
Open-market purchases · 20,400 sh · avg $24.48 · $499,374
Loading xslF345X05/ownership.xml…